NCT04731727View on ClinicalTrials.gov

Treating Corneal Thinning Conditions With CCL Vario Riboflavin (CXL)

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Keratoconus, Unstable

Interventions

DRUG

Riboflavin

Corneal cross linking achieved by combination of Riboflavin and ultraviolet light

All Listed Sponsors

lead

Kent Wellish MD

OTHER